|
|
|
|
||
Strong Buy
Re: NEJM 17Mar2022 Article "Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus" again, a tough hill to climb, though i will say that thal and then rev have and do work almost like a miracle on cutaneous lupus and i fully expect the same with iber. the challenge has been to make a dent in the other manifestations, esp renal. will be interesting to see granular data. |
return to message board, top of board |